![TY Howton](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
TY Howton
Geschäftsführer bei
SOLID BIOSCIENCES INC.
Vermögen: 1 Mio $ am 30.06.2026
Profil
David Tyronne Howton is Director at Biogene Therapeutics, Inc. since 2026.
Mr. Howton is Chief Operating Officer & Secretary at Solid Biosciences, Inc. since 2023.
Former roles include Director at Make-A-Wish Foundation of Massachusetts, Chief Healthcare Compliance Officer at Genentech, Inc., Secretary, Chief Legal Officer & Senior VP at Vertex Pharmaceuticals, Inc. in 2012, Secretary, Senior Vice President & General Counsel at Sarepta Therapeutics, Inc. from 2013 to 2020, and Chief Operating Officer & General Counsel at AavantiBio, Inc. from 2021 to 2022.
Education includes undergraduate studies at Yale University and graduate studies at Northwestern University School of Law.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.03.2026 | 105’077 ( 0.11% ) | 1 Mio $ | 30.06.2026 |
Aktive Positionen von TY Howton
| Unternehmen | Position | Beginn |
|---|---|---|
| SOLID BIOSCIENCES INC. | Geschäftsführer | 01.09.2023 |
Ehemalige bekannte Positionen von TY Howton
| Unternehmen | Position | Ende |
|---|---|---|
Aavantibio, Inc.
 Aavantibio, Inc. BiotechnologyHealth Technology Operates as biotechnology company that develops new gene therapies | Geschäftsführer | 01.12.2022 |
| SAREPTA THERAPEUTICS, INC. | General Counsel | - |
| VERTEX PHARMACEUTICALS INCORPORATED | General Counsel | 12.06.2012 |
Make-A-Wish Foundation of Massachusetts | Direktor/Vorstandsmitglied | - |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | - |
Ausbildung von TY Howton
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
59
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Vertex Pharmaceuticals, Inc.
 Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
Sarepta Therapeutics, Inc.
 Sarepta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures micro-dystrophin gene therapy | Health Technology |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Make-A-Wish Foundation of Massachusetts | |
Northwestern University School of Law
 Northwestern University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Solid Biosciences, Inc.
 Solid Biosciences, Inc. BiotechnologyHealth Technology Operates as a pharmaceutical company that develops treatments through gene therapy for patients with duchenne disease | Health Technology |
Aavantibio, Inc.
Aavantibio, Inc. BiotechnologyHealth Technology Operates as biotechnology company that develops new gene therapies | Health Technology |
